Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Kenya Multisite Integrated Surveillance of COVID-19 and Other Pathogens, KEMIS I

Domaine:

healthcare
Créateur:
Afr
Éditeur:
Zir
Éditeur:
Afr
Hôte:avatar
Reliable, representative, and timely SARS-CoV-2 seroprevalence estimates continue to be important for mapping the trajectory of the COVID-19 pandemic in Kenya, and informing disease control strategies. Including vaccination programs. Serial seroprevalence estimates in general population samples help to inform changes in SARS-CoV-2 cumulative incidence over time and changes in population immunity. Serial sero-surveys can also help identify gaps in population immunity within specific populations to inform targeted interventions, such as targeted vaccination campaigns. Furthermore, they can inform the contribution of vaccination to population immunity and can be leveraged, within population cohorts, to evaluate the duration of immunity conferred from either natural infection or vaccination.

Visit

doi.orgmicrodataportal.aphrc.org

Licenses

Creative Commons Attribution 1.0 Generichttps://creativecommons.org/licenses/by/1.0/legalcode

Similaires

Kenya Multisite Integrated Surveillance of SARS-CoV-2 and other Pathogens, KEMIS III

Kenya Multisite Integrated Surveillance of SARS-CoV-2 and other Pathogens, KEMIS III

In the dynamic landscape of COVID-19 pandemic and its implications for global health and well-being,